Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Università del Piemonte Orientale Home
Italiano
English
Cerca contenuto all’indirizzo Università del Piemonte Orientale
Home
Profili
Unità di ricerca
Apparecchiatura
Progetti
Risultato della ricerca
Diffuse large B-cell lymphoma genotyping on the liquid biopsy
Davide Rossi
, Fary Diop
, Elisa Spaccarotella
, Sara Monti
, Manuela Zanni
, Silvia Rasi
, Clara Deambrogi
, Valeria Spina
, Alessio Bruscaggin
, Chiara Favini
, Roberto Serra
, Antonio Ramponi
,
Renzo Boldorini
, Robin Foà
,
Gianluca Gaidano
Dipartimento di Medicina Traslazionale
Risultato della ricerca
:
Contributo su rivista
›
Articolo in rivista
›
peer review
Panoramica
Fingerprint
Fingerprint
Entra nei temi di ricerca di 'Diffuse large B-cell lymphoma genotyping on the liquid biopsy'. Insieme formano una fingerprint unica.
Ordina per
Peso
Alfabetico
Keyphrases
Apoptosis
11%
Biopsy Site
11%
Cell-free DNA (cfDNA)
55%
Chemotherapy
11%
Clonal Evolution
33%
Cyclophosphamide
22%
Diagnostic Biopsy
11%
Diagnostic Interventions
11%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
DNA Genotyping
22%
Doxorubicin
22%
Evolution Mechanism
11%
Genetic Mechanism
11%
Genetic Profile
11%
Liquid Biopsy
100%
Longitudinal Analysis
11%
Lymphoma Patients
11%
Metagenomic Next-generation Sequencing (mNGS)
11%
New mutation
11%
Non-invasive Approach
11%
Plasma Cell-free DNA
33%
Plasma Samples
11%
Prednisone
22%
Rapid Clearance
11%
Real-time Approach
11%
Resistance Mechanisms
11%
Resistant Clones
22%
Rituximab
22%
Tissue Biopsy
11%
Treatment-resistant
11%
Treatment-resistant Patients
11%
Tumor Biopsy
11%
Tumor Cells
11%
Tumor DNA
11%
Tumor Heterogeneity
11%
Tumor mutation Burden
11%
Ultra-deep Well
11%
Medicine and Dentistry
Allele
11%
Biopsy Technique
33%
Cell-Free DNA
88%
Cyclophosphamide
22%
Diffuse Large B-Cell Lymphoma
100%
Doxorubicin
22%
Liquid Biopsy
100%
Neoplasm
22%
Next Generation Sequencing
11%
Prednisone
22%
Programmed Cell Death
11%
Rituximab
22%
Somatics
11%
Tumor Biopsy
11%
Tumor Cell
11%
Tumour Heterogeneity
11%
Vincristine
22%
Biochemistry, Genetics and Molecular Biology
Allele
11%
B Cell
100%
Blood Plasma
11%
Clonal Evolution
33%
Cyclophosphamide
22%
Doxorubicin
22%
Genetic Mechanism
11%
Genetics
11%
Genotyping
100%
Immunoglobulin Producing Cell
33%
Next Generation Sequencing
11%
Prednisone
22%
Programmed Cell Death
11%
Rituximab
22%
Agricultural and Biological Sciences
Allele
11%
B Cell
100%
Blood Plasma
11%
Genotyping
100%
Immunoglobulin Producing Cell
33%
Prednisone
22%
Pretreatment
11%
Programmed Cell Death
11%
Rituximab
22%
Vincristine
22%
Immunology and Microbiology
Allele
11%
B Cell
100%
Blood Plasma
11%
Clonal Evolution
33%
Cyclophosphamide
22%
Immunoglobulin Producing Cell
33%
Next Generation Sequencing
11%
Prednisone
22%
Programmed Cell Death
11%
Rituximab
22%
Tumor Cell
11%